Uncertainty estimation in classification of MGMT using radiogenomics for glioblastoma patients

W. Farzana; Z. A. Shboul; A. Temtam; K. M. Iftekharuddin

doi:10.1117/12.2612621

4 April 2022 Uncertainty estimation in classification of MGMT using radiogenomics for glioblastoma patients

W. Farzana, Z. A. Shboul, A. Temtam, K. M. Iftekharuddin

Proceedings Volume 12033, Medical Imaging 2022: Computer-Aided Diagnosis; 120331E (2022) https://doi.org/10.1117/12.2612621
Event: SPIE Medical Imaging, 2022, San Diego, California, United States

Abstract

Glioblastoma Multiforme (GBM) is one of the most malignant brain tumors among all high-grade brain cancers. Temozolomide (TMZ) is the first-line chemotherapeutic regimen for glioblastoma patients. The methylation status of the O6-methylguanine-DNA-methyltransferase (MGMT) gene is a prognostic biomarker for tumor sensitivity to TMZ chemotherapy. However, the standardized procedure for assessing the methylation status of MGMT is an invasive surgical biopsy, and accuracy is susceptible to resection sample and heterogeneity of the tumor. Recently, radio-genomics which associates radiological image phenotype with genetic or molecular mutations has shown promise in the non-invasive assessment of radiotherapeutic treatment. This study proposes a machine-learning framework for MGMT classification with uncertainty analysis utilizing imaging features extracted from multimodal magnetic resonance imaging (mMRI). The imaging features include conventional texture, volumetric, and sophisticated fractal, and multi-resolution fractal texture features. The proposed method is evaluated with publicly available BraTS-TCIA-GBM pre-operative scans and TCGA datasets with 114 patients. The experiment with 10-fold cross-validation suggests that the fractal and multi-resolution fractal texture features offer an improved prediction of MGMT status. The uncertainty analysis using an ensemble of Stochastic Gradient Langevin Boosting models along with multi-resolution fractal features offers an accuracy of 71.74% and area under the curve of 0.76. Finally, analysis shows that our proposed method with uncertainty analysis offers improved predictive performance when compared with different well-known methods in the literature.

Conference Presentation

Citation Download Citation

W. Farzana, Z. A. Shboul, A. Temtam, and K. M. Iftekharuddin "Uncertainty estimation in classification of MGMT using radiogenomics for glioblastoma patients", Proc. SPIE 12033, Medical Imaging 2022: Computer-Aided Diagnosis, 120331E (4 April 2022); https://doi.org/10.1117/12.2612621

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available